Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Comirnaty TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: tozinameran
Brand name
(ARTG)
: COMIRNATY (tozinameran) COVID-19 VACCINE 3 micrograms/0.2 mL concentrated suspension for injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in individuals 6 months of age to less than 5 years of age.,The use of this vaccine should be in accordance with official recommendations.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intramuscular
- White to off-white frozen liquid.
Storage conditions
(ARTG)
- Store between minus 60 - minus 90 degrees
- Protect from Light
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 10 pack
- 195 vials pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient tozinameran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Need more information?
These trusted information partners have more on this topic.
Top results
COVID-19 vaccination when pregnant or breastfeeding and for those planning pregnancy - RANZCOG
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) acknowledges the risk posed to the community, healthcare workers, and all patients, due to the COVID-19 (coronavirus) pandemic
Read more on RANZCOG - Royal Australian and New Zealand College of Obstetricians and Gynaecologists website
COVID-19 vaccines: Frequently asked questions (FAQs) | NCIRS
COVID-19 vaccines: Frequently asked questions (FAQs) COVID-19 Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety COVID-19 Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety Key points COVID-19 is a disease caused by the SARS-CoV-2 virus
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Should I get the COVID-19 vaccination during pregnancy? | Sharing Knowledge About Immunisation | SKAI
Should I get the COVID-19 vaccination during pregnancy? Key facts COVID-19 infection in pregnancy can cause serious illness and complications for pregnant women and their babies
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Frequently Asked Questions about COVID-19 vaccines for people affected by cancer | Cancer Australia
Cancer Australia has compiled answers to Frequently Asked Questions (FAQs) about COVID-19 vaccines for people affected by cancer based on information and evidence currently available in Australia and internationally.
Read more on Cancer Australia website
Top results
COVID-19 vaccination when pregnant or breastfeeding and for those planning pregnancy - RANZCOG
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) acknowledges the risk posed to the community, healthcare workers, and all patients, due to the COVID-19 (coronavirus) pandemic
Read more on RANZCOG - Royal Australian and New Zealand College of Obstetricians and Gynaecologists website
ATAGI statement for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions | Australian Government Department of Health and Aged Care
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions.
Read more on Australian Government Department of Health and Aged Care website
COVID-19 vaccines in 2023 - Australian Prescriber
As SARS‑CoV‑2 continues to evolve, vaccines are being updated, and policymakers are reviewing the optimal timing of future booster doses to maintain adequate protection against severe illness, particularly for older adults.
Read more on Australian Prescriber website
